Jean Koff MD, MSc
Overview
Dr. Koff is a clinical investigator in the Bone Marrow and Stem Cell Transplant Center with a disease focus in lymphoma.
Dr. Koff received her MD and graduated magna cum laude from Emory University School of Medicine in Atlanta, Georgia. Her postgraduate medical education included a J. Willis Hurst Residency in Internal Medicine at Emory University and a Fellowship in Hematology and Medical Oncology at Winship Cancer Institute, where she was Chief Fellow in her final year.
She holds memberships with American Medical Association, American Society of Clinical Oncology and American Society of Hematology.
Academic Appointment
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MD from Emory University School of Medicine
Research
Publications
-
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk Volume: 25 Page(s): e183 - e199.e8
04/01/2025 Authors: Nastoupil LJ; Andersen CR; Ayers A; Wang Y; Habermann TM; Chihara D; Kahl BS; Link BK; Koff JL; Cohen JB -
Outcomes of Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated With R-GemOx: A Multicenter Cohort Study.
Am J Hematol Volume: 100 Page(s): 606 - 615
04/01/2025 Authors: Yamshon S; Koff JL; Larson MC; Kahl BS; Casulo C; Lossos IS; Haddadi S; Stanchina M; Chihara D; Ayers A -
Treatment patterns and outcomes in follicular lymphoma with POD24: an analysis from the LEO Consortium.
Blood Adv Volume: 9 Page(s): 1013 - 1023
03/11/2025 Authors: Day JR; Larson MC; Durani U; Koff JL; Wang Y; Habermann TM; Lossos IS; Nastoupil LJ; Strouse C; Chihara D -
Addressing Health Disparities in Hematologic Malignancies: from Genes to Outreach.
Blood Cancer Discov Volume: 6 Page(s): 79 - 93
03/04/2025 Authors: Flowers CR; Anantha RW; Leautaud V; Desai P; Donald CE; Hildebrandt MAT; Koff JL; Tamimi RM; Cozen W; Nze C -
Plasma Cytokine and Chemokine Profiles Predict Efficacy and Toxicity of Anti-CD19 CAR-T Cell Therapy in Large B-Cell Lymphoma.
Clin Lymphoma Myeloma Leuk
02/20/2025 Authors: Zeng F; Zhang H; Wang S; Passang T; Li Y; Funk CR; Wyman S; O'Leary CB; Abousaud AI; Liu Y -
Human immune organoids to decode B cell response in healthy donors and patients with lymphoma.
Nat Mater Volume: 24 Page(s): 297 - 311
02/01/2025 Authors: Zhong Z; Quiones-Prez M; Dai Z; Juarez VM; Bhatia E; Carlson CR; Shah SB; Patel A; Fang Z; Hu T -
T Cells Spatially Regulate B Cell Receptor Signaling in Lymphomas through H3K9me3 Modifications.
Adv Healthc Mater Volume: 14 Page(s): e2401192
02/01/2025 Authors: Britto LS; Balasubramani D; Desai S; Phillips P; Trehan N; Cesarman E; Koff JL; Singh A -
Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature.
Blood Adv Volume: 8 Page(s): 5939 - 5948
12/10/2024 Authors: Bommier C; Link BK; Gysbers BJ; Maurer MJ; Larson MC; Khurana A; Wang Y; Thompson CA; Chihara D; Alderuccio JP -
Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.
Haematologica Volume: 109 Page(s): 2177 - 2185
07/01/2024 Authors: Maurer MJ; Casulo C; Larson MC; Habermann TM; Lossos IS; Wang Y; Nastoupil LJ; Strouse C; Chihara D; Martin P -
Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors.
Adv Healthc Mater Volume: 13 Page(s): e2302425
06/01/2024 Authors: Lin HK; Uricoli B; Freeman R; Hossian AN; He Z; Anderson JYL; Neffling M; Legier JM; Blake DA; Doxie DB